ADRB2 and neoplasm: The key role of the β2-AR signaling in cancer biology has been initially demonstrated in epidemiological studies that correlated chronic stress with accelerated tumor progression [5, 6], as well as reduced tumor aggressiveness in patients under β-blockers therapy [7, 8].